Salesforce Unveils AI-Powered Agentforce for Life Sciences

Salesforce India has introduced Agentforce Life Sciences for Customer Engagement, expanding its Agentforce Life Sciences portfolio with an innovative, agent-first solution designed to transform how life sciences organizations connect with healthcare professionals (HCPs).

The launch addresses a major challenge within the industry: today’s physicians face an overwhelming information burden—75% more data per drug than a decade ago—yet only about one-third feel adequately supported. Many continue to report being overwhelmed by excessive outreach from pharmaceutical and medical device companies.

In response, Agentforce Life Sciences leverages digital labor to deliver more personalized, meaningful interactions, reducing noise while helping bridge critical care gaps. The solution redefines how drugs and medical devices are discovered, approved, accessed, and administered—empowering professionals to focus on the human side of healthcare.

Also Read: Lilly, NVIDIA Partner to Build AI Supercomputer for Drug Discover

Built natively on the Salesforce platform, Agentforce Life Sciences for Customer Engagement extends beyond traditional CRM systems by offering a conversational, consumer-grade experience backed by enterprise-level security. It enables representatives to maximize their limited time with busy practitioners through features like voice-dictated notes, advocacy scoring, radio-style briefings, and concise account summaries. With seamless, 24/7 access to critical insights, life sciences teams can engage more effectively and enhance patient outcomes.

Mankiran Chowhan, managing director - sales at Salesforce India said, “India’s life sciences sector is scaling at an incredible pace, in parallel, the engagement model with doctors needs to keep pace. With Agentforce Life Sciences, we’re fundamentally upgrading that model. We're moving from high-volume, low-impact communication to intelligent, trusted collaboration. This allows companies to serve the immense Indian market more effectively and helps empower healthcare professionals to make faster, better-informed decisions for their patients. For doctors, it means getting the right insights to better treat their patients. And for India, it means closing the gap between medical innovation and patient access."